EFFICACY, AND SAFETY STUDY OF OPTIMIZED BACKGROUND ANTIRETROVIRAL REGIMEN (OB) IN COMBINATION WITH ENFUVIRTIDE IN THE TREATMENT-EXPERIENCED PARTICIPANTS WITH HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) INFECTION: